Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being. Traditional treatments often fall short, offering temporary relief at best while ...

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It ...

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for nerve dysfunction ... regimen or advise a treatment break.